Browsing by Author Spry, N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2005Changes of bodyweight and lipids during intermittent maximum androgen blockade (IMAB) in the treatment of advanced prostate cancerBerry, Martin; Byth Wilson, Karen; Gurney, Howard; Woo, Henry; Hayden, L.; Korbel, E.; Spry, N; van Ufford-Mannesse, P.; Medical Radiation Sciences; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: SurgeryChanges of bodyweight and lipids during intermittent maximum androgen blockade (IMAB) in the treatment of advanced prostate cancer, Journal of Clinical Oncology, vol.23,(16S (June 1 Supplement)),2005,pp 418S-418S
2010Effective Communication and Information Provision in Radiotherapy - The Role of Radiation TherapistsRybovic (Short), Michala; Arnet, Hayley; Carson, Sharron; Halkett, Georgia K; Jiwa, Moyez; Kearvell, Rachel; Kristjanson, Linda. J; Merchant, Susan; Richardson, Sharon; Spry, N; Taylor, Mandy; Medical Radiation SciencesEffective Communication and Information Provision in Radiotherapy - The Role of Radiation Therapists, Journal of Radiotherapy in Practice, vol.9, 1,pp 3-16
2017Feasibility of Presurgical Exercise in Men with Prostate Cancer Undergoing ProstatectomyBaker, Michael Kevin; Galvao, Daniel; Newton, Robert; Singh, Favil; Spry, N; Taaffe, Dennis; Thavaseelan, Jeffrey; Exercise Health and PerformanceFeasibility of Presurgical Exercise in Men with Prostate Cancer Undergoing Prostatectomy, Integrative Cancer Therapies, vol.16, 3, 2017,pp 290-299
2012The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen SuppressionTurner, Sandra; Woo, Henry; Jackson, Melanie; Leong, Eugene; Ng, Evan; Spry, N; Western Clinical School: Medicine (Westmead); SAHCS: SurgeryThe Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression, The Journal of Urology, vol.187, 6, 2012,pp 2162-2167
2013Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancerTurner, Sandra; Atkinson, Chris; Christie, David; Denham, James; Joseph, David; Lamb, David; Matthews, John; North, John; Spry, N; Steigler, Allison; Tai, Keen-Hun; Wynne, Chris; Western Clinical School: Medicine (Westmead)Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer, Radiotherapy and Oncology, vol.107, 2, 2013,pp 123-128
2015Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trialTurner, Sandra Lynne; Atkinson, Chris; Denham, James; Duchesne, Gillian; et al, Various; Joseph, David; Kenny, L.; Lamb, David S; Matthews, John; Spry, N; Steigler, Allison; Central Clinical School: MedicineRadiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial, Radiotherapy and Oncology, vol.115, 3, 2015,pp 301-307